Tag | Content |
---|
EnhancerAtlas ID | HS139-44235 | Organism | Homo sapiens | Tissue/cell | Myotube | Coordinate | chr5:102597440-102599470 | TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
CDX2 | MA0465.1 | chr5:102598411-102598422 | TTTTATTGCTT | - | 6.32 | MEF2C | MA0497.1 | chr5:102599066-102599081 | TTCTATTTTTGGCTT | - | 7.85 | SOX10 | MA0442.2 | chr5:102598510-102598521 | GTCTTTGTTTT | - | 6.14 | ZNF263 | MA0528.1 | chr5:102598902-102598923 | TCCTCCTCCTCCTCCTCCTCC | - | 12.34 | ZNF263 | MA0528.1 | chr5:102598905-102598926 | TCCTCCTCCTCCTCCTCCTCC | - | 12.34 | ZNF263 | MA0528.1 | chr5:102598893-102598914 | CCATATACCTCCTCCTCCTCC | - | 6.06 | ZNF263 | MA0528.1 | chr5:102598923-102598944 | TCCTGCTCTTCCTCCTCCTCC | - | 6.63 | ZNF263 | MA0528.1 | chr5:102598944-102598965 | TCCTGCTCTTCCTCCTCCTCC | - | 6.63 | ZNF263 | MA0528.1 | chr5:102598929-102598950 | TCTTCCTCCTCCTCCTCCTGC | - | 6.77 | ZNF263 | MA0528.1 | chr5:102598908-102598929 | TCCTCCTCCTCCTCCTCCTGC | - | 7.07 | ZNF263 | MA0528.1 | chr5:102598914-102598935 | TCCTCCTCCTCCTGCTCTTCC | - | 7.31 | ZNF263 | MA0528.1 | chr5:102598935-102598956 | TCCTCCTCCTCCTGCTCTTCC | - | 7.31 | ZNF263 | MA0528.1 | chr5:102598896-102598917 | TATACCTCCTCCTCCTCCTCC | - | 7.46 | ZNF263 | MA0528.1 | chr5:102598917-102598938 | TCCTCCTCCTGCTCTTCCTCC | - | 8.14 | ZNF263 | MA0528.1 | chr5:102598938-102598959 | TCCTCCTCCTGCTCTTCCTCC | - | 8.14 | ZNF263 | MA0528.1 | chr5:102598911-102598932 | TCCTCCTCCTCCTCCTGCTCT | - | 8.58 | ZNF263 | MA0528.1 | chr5:102598932-102598953 | TCCTCCTCCTCCTCCTGCTCT | - | 8.58 | ZNF263 | MA0528.1 | chr5:102598926-102598947 | TGCTCTTCCTCCTCCTCCTCC | - | 8.5 | ZNF263 | MA0528.1 | chr5:102598899-102598920 | ACCTCCTCCTCCTCCTCCTCC | - | 9.76 | ZNF263 | MA0528.1 | chr5:102598920-102598941 | TCCTCCTGCTCTTCCTCCTCC | - | 9.76 | ZNF263 | MA0528.1 | chr5:102598941-102598962 | TCCTCCTGCTCTTCCTCCTCC | - | 9.76 |
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
| Enhancer Sequence | AAATGTTTTG GTGGGCTTCA GGTTAGGGCC ATGAAAAAAA TGAAAATAAA TGTTTTGATA 60 GCTAGAATTA GAACTCACAG CTTCTACTGT ACCAATTTCT CTGCCTAAAA TTTGTCCTTT 120 CATAATATAA ACTTTAATGA TGAATGTGAT TTTTATTTAC CAATATTTGA AAGGGCTATG 180 TGCTGGTCCT CATATTTATA GTCTTATGAT TTGTGATCAA TGTTGTTAAA TTTTTTCTTA 240 CTGCTGTTTT GTTAGTGATC TGTGCTGAAG CTTGAGATTC ACGACTTTTT TGTGTGTTTA 300 CGAATTTTGT ATGGACATAA ACATTTCCAA ATGGAGCTTT GTATATTTTT GGGAAAGGCA 360 CTCCCTTTTT TGGGTTCCTA GTGCCATTCA GGTTTACTGT TATTAGAAGG ATTTATTTCC 420 ATGTCTGCCC TCCCCTCTGA CCCAGTCTCA GGCCATCTCT TTATATGTGC ACCAGTGCCT 480 GCATAGTGTG GGGATATATA ATAAGACTTA AGAAACATTG TTGAATGACT GAATAAGTGA 540 ATATCTAAGT GGGTACACCC GAAGAAAGAA CTCAGACCTG TATGGGAATT CACCGTTCAA 600 GCAGAAGGGT GTTTCCCTTT TTAAAAAAGT CATTGCCTTT CCATGTTGCT TTTGAGTAGG 660 ATAACAAATG AAACAGCCAA ACTGAGACAC TTTTGAGAGT TAAAGGGGGT TGCTTTCAAT 720 AATTATGCCA GGGTATTGAC TATGAATTGA GATATATAGT CACTCTTCTT TTGAAAGGCA 780 TTCTTATTTA CCTGTGATAA TAACTATCAC CTGAGAAATT CGATACATTT GGTAGTTAAT 840 GTTTGCAAAC TTTTCTATTT GTAGAAGCTC CACTTGCAGT GAAATGTTGG GTGTCTTTTG 900 CTTAGTCACC CATGACTTTC TTATCCAGAA GTCTGTGGGC AGCTCTTGGC CACTGCTTGG 960 TTTTTTCCTA TTTTTATTGC TTATGGGATA ATGTCCCACT GCATTCTGTT TCAGCTTCTT 1020 ATAACTGGAA GCATTTATTA TATCTTGTAG CCTTTGCTCT ATTTACTTCA GTCTTTGTTT 1080 TTATGCAGCA TTTAGTCTAT CTTCTAAGAA TTTCACATGG ATTCCTTTTC CTCTTGCTGA 1140 CTGTTTTGGA GAGGAAATCT GTTGATATCT TTCCAAGCCT TCAGTGTTTA GAACATTGGC 1200 CAAAATCAGT TGCAAGCGTT AGAGAATTAT AGATTTTTAA AGTATTCTAA AAATGTGTGT 1260 TATTTGAAAG GTACATGTTT TGGGAATTTT TATATTACAA TCTTTTAATT GTTATAAGTG 1320 GGAGATGGGG GTAGAACCCT TACTGTAATT TTGTAGTAGA TTTCTTTATG GGTTATGTCT 1380 TAAAGAAAAC GTATAATCTT ATACTAGTTA GTTTCTGGTC TTGTTCTTTT TATTTATTTT 1440 TCCCTCTTTT TCACCATATA CCTCCTCCTC CTCCTCCTCC TCCTCCTGCT CTTCCTCCTC 1500 CTCCTCCTGC TCTTCCTCCT CCTCCCACAA AGCAGGAAGC AGAGTCAAAA TTAGAAAAAG 1560 TGAGAATGTA ATGGAGCTTC TGCACCTTGG TTTTCTTGTG TTGCTCCCTT GGACATTGTG 1620 TTTATATTCT ATTTTTGGCT TGGCACTGGC ATAATAGGAA TAATCAGTTA CTACTCTTTG 1680 TTTACTATGA AATTACCGAT CATTTCCTAG ATTTACACAT CAGCTCCAGT GCAAGAGTTG 1740 GGTAATGTCT TCAAGGCTCC TCTGCTTTCA AATCCAGACT AAAGTTTTAG TTGATTTCTT 1800 TCTTTTGATG TTGAAAAAGA AACTCTTTGA AAGTGTAAAT ATTTTTCTAA TGCATTTAAA 1860 AGCTTAAAAA GAAGAATATG TCACCAAATA CATGAGGCAA ATTATATGAA AGTTTGAATG 1920 AGATTTAAGA CTGTCAAAAC TATTCTTTAG GATTAAGACA TTCAGATATT TCTAATGTTC 1980 CTCCTGCTTG TTTTAAATTG ACATTTATAA AAGTATAAAT GAAATCTATC 2030
|
| |
|
|
|